Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Jinxin Fertility Completes Financing Led by Warburg and CNCB

publication date: Oct 9, 2018

Jinxin Fertility, a company providing assisted reproductive technology services, received a strategic investment led by Warburg Pincus and CNCB Investment, a CITIC unit. Jinxin ranks second in China in terms of number of reproductive procedures performed. The company has centers in Chengdu, Shenzhen and the US, the latter providing services that are not available in China. Sequoia Capital China and WuXi AppTec also participated in the investment, whose size was not disclosed. Jinxin Fertility is headquartered in Chengdu, Sichuan Province. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital